Editorials

Heroin overdose: the case for take-home naloxone

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7044.1435 (Published 08 June 1996) Cite this as: BMJ 1996;312:1435
  1. John Strang,
  2. Shane Darke,
  3. Wayne Hall,
  4. Michael Farrell,
  5. Robert Ali
  1. Professor and director National Addiction Centre, London SE5 8AF
  2. Senior lecturer Professor and director National Drug and Alcohol Research Centre, Sydney, NSW, Australia
  3. Senior lecturer National Addiction Centre, London SE5 8AF
  4. Director of clinical policy and research Drug and Alcohol Services Council, Adelaide, SA, Australia

    Home based supplies of naloxone would save lives

    Non-fatal overdose is an occupational risk of heroin misuse1 and fatal overdose is a common cause of premature death in heroin users.2 3 4 One of the major contributors to a fatal outcome is the inadequacy of heroin users' responses to the overdoses of their peers. They may delay calling an ambulance for fear of the police arriving, and their efforts to revive comatose users are often ineffective. The distribution of naloxone to opiate users was first mooted in 19925 as an intervention that would be life saving in such situations.6 With a rising toll of deaths from heroin overdose it is time to take the suggestion seriously.

    Interviews with 320 heroin users in Sydney found that two thirds had had a drug overdose, a third within the past year, and that 80% had been present at the overdose of another user.7 In Australia the incidence of deaths from heroin overdose has increased over the past decade while deaths from other drug related causes have fallen. In the United Kingdom a sharp increase in the numbers of deaths among opiate users has recently been …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe